Prevalence of dyslipidemia in statin-treated patients in Canada: Results of the DYSlipidemia International Study (DYSIS)

Canadian Journal of Cardiology

Volumn 26, Issue 9, 2010, Pages

  Goodman, Shaun G ^a,b   Langer, Anatoly ^a,b   Bastien, Natacha R ^c   McPherson, Ruth ^d   Francis, Gordon A ^e   Genest Jr , Jacques J ^f   Leiter, Lawrence A ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b CANADIAN HEART RESEARCH CENTRE   (Canada)

^c MERCK FROSST CENTRE FOR THERAPEUTIC RESEARCH   (Canada)

^d UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^f MCGILL UNIVERSITY   (Canada)

Author keywords

Cholesterol; Dyslipidemia; Lipids

Indexed keywords

ATORVASTATIN; BILE ACID SEQUESTRANT; EZETIMIBE; FIBRIC ACID DERIVATIVE; FLUINDOSTATIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN; NICOTINIC ACID; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN;

ADULT; AGED; ARTICLE; CANADA; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; DYSLIPIDEMIA; FEMALE; HIGH RISK POPULATION; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OBSERVATIONAL STUDY; PRACTICE GUIDELINE; PREVALENCE;

EID: 78549284353     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0828-282X(10)70454-2     Document Type: Article

References (13)

1. Cholesterol Treatment Trialists' (CTT) Collaborators. Efficacy and safety of cholesterol-lowering treatment: Prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005;366:1267-78.
2. McPherson R, Frolich J, Fodor G, Genest J. Canadian Cardiovascular diagnosis and treatment Society position statement - recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease. Can J Cardiol 2006;22:913-27.
3. Grima DT, Leiter LA, Goodman SG, Attard CL, Chow C-M, Langer A. How many cardiovascular events can be prevented with optimal management of high-risk Canadians? Can J Cardiol 2008;24:363-8.
4. Yan AT, Yan RT, Tan M, et al. Contemporary management of dyslipidemia in high risk patients: Targets still not met. Arch Intern Med 2006;119:676-83.
5. Teoh H, Mendelsohn AA, Goodman SG, et al. Usefulness of statin-ezetimibe combination to reduce the care gap in dyslipidemia management in patients with a high risk of atherosclerotic disease. Am J Cardiol 2009;104:798-804.
6. Gitt AK, Kastelein JPP; on behalf of the DYSIS Study Group. High prevalence of dyslipidemia in 18,574 patients treated with statins in Europe and Canada: Results of the Dyslipidemia International Study. Eur Heart J 2009;30:303. (Abst)
7. Pearson TA, Laurora I, Chu H, Kafonek S. The Lipid Treatment Assessment Project (L-TAP): A multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals. Arch Intern Med 2000;160:459-67.
8. National Cholesterol Education Program (NCEP) Expert Panel on Detection EaToHBCiAATPI. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report. Circulation 2002;106:3143-421.
9. Leiter LA, Martineau P, de Teresa E, et al. How to reach LDL targets quickly in patients with diabetes or metabolic syndrome. J Fam Prac 2008;57:661-8.
10. Davidson MH, Maki KC, Pearson TA, et al. Results of the National Cholesterol Education (NCEP) Program Evaluation Project Utilizing Novel E-Technology (NEPTUNE) II Survey and Implications for Treatment Under the Recent NCEP Writing Group Recommendations. Am J Cardiol 2005;96:556-63.
11. Mosca L, Merz NB, Blumenthal RS, et al. Opportunity for intervention to achieve American Heart Association guidelines for optimal lipid levels in high-risk women in a managed care setting. Circulation 2005;111:488-93.
12. Svilaas A, Risberg K, Thoresen M, Ose L. Lipid treatment goals achieved in patients treated with statin drugs in Norwegian general practice. Am J Cardiol 2000;86:1250-3.
13. Genest J, McPherson R, Frolich J, et al. 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendations. Can J Cardiol 2009;25:567-79.